Tirzepatide is the active ingredient in Zepbound, the FDA approved prescription medicine for Obstructive Sleep Apnea.

By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...

For about 25 million Americans who suffer from obstructive sleep apnea, there are various effective treatments such as CPAP breathing machines, surgery, a dental mouthpiece and even an implantable pac ...

and central sleep apnea (CSA). In both cases, CPAP machines and sleep masks are often recommended as treatment. Research estimates close to a billion people worldwide experience OSA, in mild to ...

July 23, 2024 — Nearly 40 million adults in the U.S. have sleep apnea, and more than 30 million of them use a continuous positive airway pressure (CPAP) machine while sleeping. However ...

Medical technology company Nyxoah has officially launched its Genio system, a small implant that has the potential to treat obstructive sleep apnea (OSA) without the need for a CPAP machine.

Since sleep apnea affects nearly a billion people worldwide, and using a CPAP machine (the standard treatment for sleep apnea) can be cumbersome, the approval by the Food and Drug Administration ...

The FDA on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity.

Diagnosis involves polysomnography, and treatment options include CPAP machines ... These are obstructive, central and mixed sleep apnea. Let’s see what each one is about.

“A 10-year-old with uncontrolled central sleep apnea is about 200 times more likely ... undergoing continuous positive airway pressure (CPAP)/bi-level positive airway pressure therapy had ...

“Today’s approval marks the first drug treatment option for certain patients with obstructive sleep apnea,” said Sally Seymour, M.D., director of the Division of Pulmonology, Allergy, and Critical ...